Skip to main content

Advertisement

Fig. 5 | Parasites & Vectors

Fig. 5

From: Changes in the neuropeptide content of Biomphalaria ganglia nervous system following Schistosoma infection

Fig. 5

Neuropeptide precursor abundance in the B. glabrata CNS of non-infected versus at pre-patent stage, based on LC-MS/MS quantitative analysis. The label-free quantification module (PEAKS Q) of PEAKS v7.0 was used to compare relative concentrations of proteins at the two stages. Biological triplicates of each stage were used in tandem repeats and compared. Proteins with fold change ≥1.5 were shown (see Additional file 1: Table S1 for more details)

Back to article page